Salveo Capital invests in PathogenDx

Salveo Capital said agreed to buy a minority stake in PathogenDx. Financial terms weren’t announced. PathogenDx, of Tucson, Arizona, provides DNA-based pathogen testing kits for the cannabis, botanical, food and agriculture industries.

17 July 2018•4 mins read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles